Ovarian carcinoma

You have access
Randomized Clinical Trials and Real World Prospective Observational Studies on Bevacizumab, PARP Inhibitors, and Immune Checkpoint Inhibitors in the First-Line Treatment of Advanced Ovarian Carcinoma: A Critical Review
ANGIOLO GADDUCCI and STEFANIA COSIO

Anticancer Research October 2021, 41 (10) 4673-4685; DOI: https://doi.org/10.21873/anticanres.15281
You have access
Pegylated Liposomal Doxorubicin/Oxaliplatin Chemotherapy Can Overcome Cisplatin Resistance in Spectrin αII-Overexpressing Ovarian Carcinoma
OSAMU MAEDA, HIROAKI KAJIYAMA, KIYOSUMI SHIBATA, SHIGEO NAKAMURA and FUMITAKA KIKKAWA

Anticancer Research May 2020, 40 (5) 2497-2507; DOI: https://doi.org/10.21873/anticanres.14220
You have access
AXL Downstream Targeting Unravels Synergistic Drug Combinations in Ovarian Carcinoma Cells
DESIRÈ M. ALAMPI, EMILIO CIUSANI, NIVES CARENINI, ELISABETTA CORNA, LAURA GATTI and CRISTINA CORNO

Anticancer Research July 2019, 39 (7) 3803-3808; DOI: https://doi.org/10.21873/anticanres.13529
You have access
Promoter Methylation Down-regulates Osteoprotegerin Expression in Ovarian Carcinoma
JI-YE KIM, SE HOON KIM and HYUN-SOO KIM

Anticancer Research May 2019, 39 (5) 2361-2367; DOI: https://doi.org/10.21873/anticanres.13353
You have access
Value of Diaphragmatic Surgery During Interval Debulking Surgery
AURELIE PELISSIER, OONA FRANKE, EMILE DARAI, GILLES HOUVENAEGHEL, ELISABETH CHEREAU and ROMAN ROUZIER

Anticancer Research January 2018, 38 (1) 411-416;
You have access
Expression of Polypeptide N-Acetylgalactosaminyltransferase-6 in Epithelial Ovarian Carcinoma
MIDORI MURAKAMI, SEIJI KAGAMI, THUY THI NGUYEN, CHIHO KOI, TOMOKO KURITA and TORU HACHISUGA

Anticancer Research July 2017, 37 (7) 3911-3915;
You have access
Computational and Immunohistochemical Analyses Highlight AXL as a Potential Prognostic Marker for Ovarian Cancer Patients
LUDMILA LOZNEANU, PATRIZIA PINCIROLI, DELIA APOSTOL CIOBANU, MARIA LUISA CARCANGIU, SILVANA CANEVARI, ANTONELLA TOMASSETTI and IRINA-DRAGA CĂRUNTU

Anticancer Research August 2016, 36 (8) 4155-4163;
You have access
Correlation Between CA125 Levels After Sixth Cycle of Chemotherapy and Clinical Outcome in Advanced Ovarian Carcinoma
ANGIOLO GADDUCCI, ALICE MENICHETTI, ILARIA GUIGGI, MARGHERITA NOTARNICOLA and STEFANIA COSIO

Anticancer Research February 2015, 35 (2) 1099-1104;
You have access
Distinct Expression and Localization of TNF System in Ovarian Carcinoma Tissues: Possible Involvement of TNF-α in Morphological Changes of Ovarian Cancerous Cells
BENJAMIN PIURA, LIAT MEDINA, ALEX RABINOVICH, VICTOR DYOMIN, RUTHY SHACO LEVY and MAHMOUD HULEIHEL

Anticancer Research February 2014, 34 (2) 745-752;
You have access
How Liposomal Cisplatin Overcomes Chemoresistance in Ovarian Tumour Cells
DANIEL PHILIPP STÖLTING, MICHAELA BORRMANN, MARTIN KOCH, MICHAEL WIESE, HANS-DIETER ROYER and GERD BENDAS

Anticancer Research January 2014, 34 (1) 525-530;

Main menu

User menu

Search

Ovarian carcinoma

Pages